Authors:
Harries, AD
Gausi, FK
Kwanjana, JH
Nyirenda, TE
Salaniponi, FML
Citation: Ad. Harries et al., Is oral intermittent initial phase anti-tuberculosis treatment associated with higher mortality in high HIV-prevalent areas in sub-Saharan Africa?, INT J TUBE, 5(5), 2001, pp. 483-485
Authors:
Chimzizi, RB
Harries, AD
Hargreaves, NJ
Kwanjana, JH
Salaniponi, FM
Citation: Rb. Chimzizi et al., Care of HIV complications in patients receiving anti-tuberculosis treatment in hospitals in Malawi, INT J TUBE, 5(10), 2001, pp. 979-981
Authors:
Salaniponi, FML
Gausi, F
Kwanjana, JH
Harries, AD
Citation: Fml. Salaniponi et al., Time between sputum examination and treatment in patients with smear-negative pulmonary tuberculosis, INT J TUBE, 4(6), 2000, pp. 581-583
Authors:
Harries, AD
Hargreaves, NJ
Kumwenda, J
Kwanjana, JH
Salaniponi, FM
Citation: Ad. Harries et al., Trials of anti-tuberculosis treatment in areas of high human immunodeficiency virus prevalence in sub-Saharan Africa, INT J TUBE, 4(11), 2000, pp. 998-1001
Authors:
Harries, AD
Hargreaves, NJ
Kwanjana, JH
Salaniponi, FML
Citation: Ad. Harries et al., Relapse and recurrent tuberculosis in the context of a National Tuberculosis Control Programme, T RS TROP M, 94(3), 2000, pp. 247-249